|
|
Article: Antigen Express wins Japanese patent for certain Ii-Key compounds.
- Article from:
- Immunotherapy Weekly
- Article date:
- June 9, 2004
CopyrightCOPYRIGHT 2004 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
2004 JUN 9 - (NewsRx.com & NewsRx.net) -- Generex Biotechnology Corp. (GNBT) announced the award of Japan patent 3534761 to its Antigen Express affiliate for certain Ii-Key immunologically active compounds and their use in modifying immune responses to antigenic eptitopes recognized by T helper and T suppressor cells.
"We are very pleased, after many years of review, that the Patent Office of Japan has awarded us a significant patent, which was previously awarded in the United States," said Dr. Robert Humphreys, executive vice president of Antigen Express and chief scientific officer. "These compounds have great potential to protect against or control the course ...